Post-earnings recap
Reported
Thu, Jul 21, 2011
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
Eli Lilly's earnings report showed a slight miss on EPS, which typically raises concerns among investors. However, the stock rose by 3.01%, indicating that investors are optimistic about the company's long-term strategy and growth potential. Management's focus on research and development may have reassured investors despite the EPS miss.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.18 | N/A | -0.59% |
Overall, management conveyed a positive outlook despite the slight EPS miss. They emphasized their commitment to innovation and market expansion.
Management expressed confidence in the long-term growth strategy.
They highlighted ongoing investments in research and development.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—